Evolution of drug resistance in experimental populations of Candida albicans.
about
Genomic Plasticity of the Human Fungal Pathogen Candida albicansCiclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factorsThe Shu complex, which contains Rad51 paralogues, promotes DNA repair through inhibition of the Srs2 anti-recombinase.Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistanceGlobal analysis of the evolution and mechanism of echinocandin resistance in Candida glabrataGenetic and genomic architecture of the evolution of resistance to antifungal drug combinationsDevelopment of a novel multiplex DNA microarray for Fusarium graminearum and analysis of azole fungicide responses.Mechanisms and significance of fungicide resistance.Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.Highly efficient concerted evolution in the ribosomal DNA repeats: total rDNA repeat variation revealed by whole-genome shotgun sequence dataHaplotype mapping of a diploid non-meiotic organism using existing and induced aneuploidiesRapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.Haplotyping a Non-meiotic Diploid Fungal Pathogen Using Induced Aneuploidies and SNP/CGH Microarray AnalysisA tradeoff drives the evolution of reduced metal resistance in natural populations of yeastNoise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability.Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicansMultilocus sequence typing (MLST) for lineage assignment and high resolution diversity studies in Trypanosoma cruzi.Adaptive evolution of Escherichia coli K-12 MG1655 during growth on a Nonnative carbon source, L-1,2-propanediol.Multilocus genotyping indicates that the ability to invade the bloodstream is widespread among Candida albicans isolatesDivergence in fitness and evolution of drug resistance in experimental populations of Candida albicansLactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.Population genomics of drug resistance in Candida albicans.Population structure and properties of Candida albicans, as determined by multilocus sequence typing.Regulatory circuitry governing fungal development, drug resistance, and disease.Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazoleAntimicrobial peptides: therapeutic potential for the treatment of Candida infections.Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiaeSerial passaging of Candida albicans in systemic murine infection suggests that the wild type strain SC5314 is well adapted to the murine kidney.Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.Loss of heterozygosity of FCY2 leading to the development of flucytosine resistance in Candida tropicalis.Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation.Gene copy number polymorphisms in an arbuscular mycorrhizal fungal populationPotent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six Oral Candida Species and the Synergy with Fluconazole against Azole-Resistant Candida albicansA Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.Does stress induce (para)sex? Implications for Candida albicans evolutionChanges in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia.Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.Oral health and morbidity--implications of oral infections on the elderly.
P2860
Q21999033-F5C0F2ED-8F5C-421E-82D2-54930EB8EA6BQ24670154-6670AF97-5D85-4743-8C96-DF871074AE88Q27933060-904045BC-94FC-431E-90ED-12E0E456221DQ28476322-545B24A5-6F55-4418-8DA4-2689239FE2E4Q28483785-1BB421D8-1F30-40FD-8D24-45243B484E04Q28486002-223E8CAD-E818-44D1-A6D3-57281C4D4112Q30318491-27994E91-FA28-4A94-82A5-593203E3A86CQ30319644-03CCF72F-8E67-4E69-8678-2D2C856BF9ECQ30319796-DF368E55-5F86-4143-9ED4-2D3FB10AFAF6Q31089487-91F8A8D2-0A90-4255-9D25-367EDBB65460Q33313490-BEC8FCEC-E466-4E3E-91D9-4B803EA5FD9AQ33806807-C3565BC0-3E7B-4649-8B1F-F9B8ACBF3E6AQ33828337-1E1B1156-C6EE-4B57-BA2E-500A73F01D18Q33869677-2E297E6A-335E-4B35-B2E7-610E30A0CB11Q33895328-72281915-0FB7-4579-B4B0-0E9B95FC1A6AQ33935383-2E022BDF-868C-4D9C-8D96-416235393AB0Q33945470-7E9BB562-CC3A-47D5-8C74-CB8483D1754CQ33963271-B6532EF8-FFC0-412B-B5D2-AE58039369BDQ33972089-57751DC3-DA35-4335-8207-93EC85AF8E3BQ33996119-DFA6C9A7-9E6F-4F05-A19E-34327268FBA4Q34007871-4423616B-1E7A-48BB-8929-1241B8F1FCA7Q34034817-82D41FB8-0F75-42CF-A98B-2976A886B43BQ34143749-78A8CF57-6F7F-47CB-8BAE-A34B5F9610A3Q34190284-9AA96A65-E997-4E26-B21F-EE071E703CF8Q34230214-86914774-32E3-4919-84C1-D1915A504B2BQ34519189-72486B38-9411-47DC-90F6-200EE2C99A72Q34617356-0B42AC8F-96BA-452C-9855-9D4436C5BCC0Q34758807-8C7A0E3E-58B2-47AA-B903-9A4D7453159EQ34947163-DF4E8325-ED6D-42C9-BF80-A530A2A66E64Q35005086-9518A1A8-2A83-4FF6-AF50-872B2A950DCFQ35073460-0EDB7543-08CD-4A77-90E4-C2E07342C024Q35164402-1F561915-C156-4431-B49D-381E1A292A1BQ35633976-836444AA-1644-4703-A9BD-3A6DF3B87696Q35794052-D403D3C1-6633-46D0-BD9B-1883AC866C80Q35874892-277C6CD3-4C18-4A8E-B732-F6462FA8AAB8Q35923107-E4B52DB2-F701-4B3B-A1F5-2739633E2B1DQ35947465-42E51F2E-7637-4A09-A205-4FC0BEDD3958Q36095337-CD6BC3E8-2A11-43A4-BD1C-34028C86C863Q36161987-3AB26EBB-B4CF-4576-B177-206C133B9228Q36376461-4E236FAF-ED64-4267-9918-177E4891015F
P2860
Evolution of drug resistance in experimental populations of Candida albicans.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evolution of drug resistance in experimental populations of Candida albicans.
@ast
Evolution of drug resistance in experimental populations of Candida albicans.
@en
type
label
Evolution of drug resistance in experimental populations of Candida albicans.
@ast
Evolution of drug resistance in experimental populations of Candida albicans.
@en
prefLabel
Evolution of drug resistance in experimental populations of Candida albicans.
@ast
Evolution of drug resistance in experimental populations of Candida albicans.
@en
P2093
P2860
P1476
Evolution of drug resistance in experimental populations of Candida albicans
@en
P2093
C Sirjusingh
D Calabrese
J B Anderson
P2860
P304
P356
10.1128/JB.182.6.1515-1522.2000
P407
P577
2000-03-01T00:00:00Z